NCT00024934View on ClinicalTrials.gov

B-Lymphocyte Stimulator (BLyS) To Treat Selective IgA Deficiency

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2001

Study Completion Date

August 31, 2004

Conditions
IgA Deficiency
Interventions
DRUG

B-Lymphocyte Stimulator (BLyS)

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00024934 - B-Lymphocyte Stimulator (BLyS) To Treat Selective IgA Deficiency | Biotech Hunter | Biotech Hunter